Generation of two hiPSCs lines of two patients carrying truncating mutations in the dimerization domain of filamin C

Stem Cell Res. 2024 Apr:76:103320. doi: 10.1016/j.scr.2024.103320. Epub 2024 Jan 27.

Abstract

Here we introduce the human induced pluripotent stem cell lines (hiPSCs), HIMRi004-A and HIMRi005-A from dermal fibroblasts of a 48-year-old female (HIMRi004-A) carrying missense mutation that translate to the first described filamin C isoform p.W2710X and from a 56-year-old female (HIMRi005-A) carrying a recently described mutation in the same domain p.Y2704X. Both lines are generated via lentiviral expression of OCT4, SOX2, KLF4 and c-MYC. The lines display a typical embryonic stem cell-like morphology, express pluripotency markers, retain a normal karyotype (46, XX) and have the differentiation capacity in all three germ layers. The two lines can be used to elucidate the pathomechanisms of FLNC myofibrillar myopathies and to develop novel therapeutic options.

MeSH terms

  • Cell Differentiation / genetics
  • Cell Line
  • Dimerization
  • Female
  • Fibroblasts / metabolism
  • Filamins / genetics
  • Filamins / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Kruppel-Like Factor 4
  • Middle Aged
  • Mutation / genetics

Substances

  • Filamins
  • Kruppel-Like Factor 4